Ayurvedic Obesity Shivagutika Pills
Shivagutika – 1000 Pills
9,555.00 Add to Cart

Shivagutika – 1000 Pills


Or 3 interest free payments of 3,185.00 with

Chief Ingredients: Shilajatu, Triphala, Bala, Amruta, Yestimadhu, Talispatra.

  Request a Callback
Buy Now

Ayurvedic Obesity Shivagutika Pills (32 Pills) by B.V. PUNDITS is an ayurvedic medicine. Shiva gutika is widely used in the treatment of liver disorders, respiratory issues, and neuropsychiatric conditions.

Ayurvedic Obesity Shivagutika Pills uses:  

  • It is used in the treatment of liver and spleen disorders, ascites, hiccup, rhinitis, bronchitis, cough, anemia, cardiac diseases, vomiting, gout arthritis and skin diseases.
  • It is also used in the treatment of epilepsy and psychotic diseases.

Doctors also use this for the treatment of
IBS – Irritable bowel syndrome

Indication: Shivagutika (32 Pills) is chiefly indicated in cancer, tumors, enlargement of the liver, Hodgkin’s disease etc., Shivagutika is useful as a local application in tonsils, adenoids, polypus and local growths. Combined with Guggulutiktaka Ghrita it may also be employed in the treatment of brain tumors and cancerous growths.

Direction of Use : The pill is a 2 g pill the pill is to be broken/cut into four equal pieces and 2 pieces equalling half a pill to be.

It is used in the treatment of liver and spleen disorder. Rhinitis, bronchitis, cough, anemia, cardiac disorders, vomiting, skin diseases, arthritis. Also used in epilepsy and psychotic diseases.

Shiva Gulika dose:  6 grams in divided dose in a day. It is administered with milk, meat soup, pomegranate juice, raisins, appropriate asava and arishta based on the target disease.

NOTES : 1 hr before food.

Click here for more Ayurvedic Medicine : Ayurvedic Medicine

Additional information


16 Pills


There are no reviews yet.

Be the first to review “Shivagutika – 1000 Pills”

Your email address will not be published. Required fields are marked *

No more offers for this product!

General Inquiries

There are no inquiries yet.